CRISPR Therapeutics AG Data Update Call

19/11/2019 8:00

שיחת ועידה Crispr Therapeutics AG

Crispr Therapeutics AG Conference call will be held on 19/11/2019. During the earnings conference call's session Crispr Therapeutics AG will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Crispr Therapeutics AG for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
You should read the following discussion together with our consolidated financial statements and related notes and other financial information appearing in this prospectus. Some of the information contained in this discussion or set forth elsewhere in this prospectus includes forward-looking statements that involve risks and uncertainties. You should review the sections of this prospectus captioned "Risk Factors" and "Special Note Regarding Forward-Looking Statements" for a discussion of important factors that could cause our actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Overview We are a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.    
קרא עוד שיחת ועידה

Crispr Therapeutics AG (CRSP)

Aeschenvorstadt 36, Basel Basel-Stadt (Basle Town) 4051, Switzerland